These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8420566)

  • 1. Expect calls from pharmacists as DUR process gears up.
    Owen JA
    Va Med Q; 1993; 120(1):31. PubMed ID: 8420566
    [No Abstract]   [Full Text] [Related]  

  • 2. Prior authorization made simple.
    Owen JA
    Va Med Q; 1993; 120(4):184-5. PubMed ID: 8251554
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicaid's new prescription drug legislation: prudent purchasing and drug use review.
    Coster JM
    Alaska Med; 1991; 33(4):147-50. PubMed ID: 1816731
    [No Abstract]   [Full Text] [Related]  

  • 4. 'Reasonable, collegial' effort expected from new drug board.
    Owen JA
    Va Med Q; 1992; 119(4):222-3. PubMed ID: 1390973
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
    Fed Regist; 1992 Nov; 57(212):49397-412. PubMed ID: 10122482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacy mandates and practice standards now taking effect under OBRA '90 deadline.
    Fern FH
    Healthspan; 1993 Mar; 10(3):12-4. PubMed ID: 10125342
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs.
    Tieman J
    Mod Healthc; 2002 Apr; 32(17):28-31. PubMed ID: 12024771
    [No Abstract]   [Full Text] [Related]  

  • 8. Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.
    Soumerai S
    J Clin Psychiatry; 2003; 64 Suppl 17():19-22. PubMed ID: 14680423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical judgment and therapeutics.
    Somberg JC
    Am J Ther; 1999 Nov; 6(6):291-2. PubMed ID: 11329111
    [No Abstract]   [Full Text] [Related]  

  • 10. Interdisciplinary grand rounds. Legal consequences of prescribing an approved drug for a non-approved use: cimetidine; a case in point.
    Danziger LH; Cowan D
    Health Matrix; 1983; 1(1):51-7. PubMed ID: 10262829
    [No Abstract]   [Full Text] [Related]  

  • 11. Va. doctors to report controlled substances. Program targets drugs with high potential for abuse, e.g., oxycontin, percocet.
    Lubell J
    Mod Healthc; 2006 Jun; 36(26):32. PubMed ID: 16841650
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final rule issued on Medicaid DUR and patient counseling.
    Am J Hosp Pharm; 1994 Dec; 51(24):3016, 3019. PubMed ID: 7856617
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule.
    Fed Regist; 1994 Sep; 59(184):48811-25. PubMed ID: 10137645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care.
    Katz MH; Kotabe S
    Med Care; 2008 Sep; 46(9):1002. PubMed ID: 18725857
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-OBRA '90 Medicaid survey: how community pharmacy practice is changing.
    Pugh CB
    Am Pharm; 1995 Feb; NS35(2):17-23. PubMed ID: 7900647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of access restrictions on the vintage of drugs used by Medicaid enrollees.
    Lichtenberg FR
    Am J Manag Care; 2005 Jan; 11 Spec No():SP7-13. PubMed ID: 15700904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 19. Too much medicine?
    Williams B
    Tenn Med; 2006 Apr; 99(4):19-23. PubMed ID: 16704125
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
    Headen A; Masia N
    Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.